Treatment resistant depression in Stockholm (TRIST) study: Patient Characteristcs, Healthcare Utilization and Treatment Patterns

Study identification

• EU PAS number:
  EUPAS25646
• Study ID:
  50315
• Official title and acronym:
  Treatment resistant depression in Stockholm (TRIST) study: Patient Characteristcs, Healthcare Utilization and Treatment Patterns
• DARWIN EU® study:
  No
• Study countries:
  Sweden
• Study status:
  Finalised

Research institutions and networks

Institutions

Forskning och Innovation

Study timelines

Date when funding contract was signed

Planned:01/11/2017

Actual:19/12/2017

Study start date

Planned:29/09/2018

Actual:07/12/2018

Date of final study report

Planned:31/12/2022

Actual:15/12/2022

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Janssen-Cilag AB, Sweden

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable